Results 201 to 210 of about 1,052,447 (319)
The Effects of Carnosine on Cognitive Function and Mental Health-A Systematic Review and Meta-Analysis. [PDF]
Hsiao YF, Fan Z, Fan YY, Chung M.
europepmc +1 more source
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
Commentary: Winning a competition predicts dishonest behavior
Yin Wu +3 more
doaj +1 more source
Application of Photostimulation Therapy in Cognitive Function of Alzheimer's Disease Patients: A Scoping Review. [PDF]
Xu B +6 more
europepmc +1 more source
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source
Operationalization of mild cognitive impairment: a graphical approach.
Fiona E Matthews +5 more
doaj +1 more source
Impact of Different Types of Sedentary Behaviour on Cognitive Function in Older Adults: A Systematic Review. [PDF]
de Jesus Silva TR +5 more
europepmc +1 more source
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe +7 more
wiley +1 more source
Association between hemoglobin glycation index and cognitive function: Evidence in the elderly. [PDF]
Ge L, Guo Y, Xu X, Xu J, Hu M.
europepmc +1 more source
Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified STAM3mP Score
ABSTRACT Early identification of patients with treatment‐responsive rapidly progressive dementia (RPD) is important as early treatment improves outcomes. The STAM3P score identifies treatment‐responsive RPD using “high risk” presenting features. We optimized performance by adding a time component (i.e., dementia within 3 months) and validated the ...
R. W. van Steenhoven +16 more
wiley +1 more source

